{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:12:23Z","timestamp":1790701943560,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"vor","delay-in-days":384,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011658","name":"French Infrastructure for Integrated Structural Biology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007391","name":"Association pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011658","name":"French Infrastructure for Integrated Structural Biology","doi-asserted-by":"publisher","award":["ANR - 10-INSB-05-01"],"award-info":[{"award-number":["ANR - 10-INSB-05-01"]}],"id":[{"id":"10.13039\/501100011658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R01CA047148-25"],"award-info":[{"award-number":["5R01CA047148-25"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008192","name":"Automotive Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Chemical Biology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.chembiol.2018.09.010","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T10:48:08Z","timestamp":1539254888000},"page":"1506-1518.e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Tetracyclines Modify Translation by Targeting Key Human rRNA Substructures"],"prefix":"10.1016","volume":"25","author":[{"given":"Jonathan D.","family":"Mortison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Schenone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob A.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie","family":"Ciarlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eamon","family":"Comer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Kundhavai","family":"Natchiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno P.","family":"Klaholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2018.09.010_bib1","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1021\/jm00046a003","article-title":"\u201cGlycylcyclines\u201d. 3. 9-Aminodoxycyclinecarboxamides","volume":"37","author":"Barden","year":"1994","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2018.09.010_bib2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate - a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J.\u00a0R. Stat. Soc. Series B"},{"key":"10.1016\/j.chembiol.2018.09.010_bib3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.pupt.2012.06.010","article-title":"Doxycycline exhibits anti-inflammatory activity in CF bronchial epithelial cells","volume":"25","author":"Bensman","year":"2012","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.chembiol.2018.09.010_bib4","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/S0968-0896(01)00063-3","article-title":"A tetracycline-binding RNA aptamer","volume":"9","author":"Berens","year":"2001","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.chembiol.2018.09.010_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd4505","article-title":"Targeting the translation machinery in cancer","volume":"14","author":"Bhat","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chembiol.2018.09.010_bib6","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/art.21122","article-title":"Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial","volume":"52","author":"Brandt","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.chembiol.2018.09.010_bib7","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0092-8674(00)00216-6","article-title":"The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit","volume":"103","author":"Brodersen","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2018.09.010_bib8","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.1093\/nar\/gkn424","article-title":"Features of 80S mammalian ribosome and its subunits","volume":"36","author":"Budkevich","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.chembiol.2018.09.010_bib9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s10753-009-9111-9","article-title":"Tetracyclines and chemically modified tetracycline-3 (CMT-3) modulate cytokine secretion by lipopolysaccharide-stimulated whole blood","volume":"32","author":"Cazalis","year":"2009","journal-title":"Inflammation"},{"key":"10.1016\/j.chembiol.2018.09.010_bib10","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1200\/JCO.2005.04.2614","article-title":"Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS Malignancy Consortium Study","volume":"24","author":"Dezube","year":"2006","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.chembiol.2018.09.010_bib58","first-page":"486","article-title":"Features and development of Coot","volume":"D66","author":"Emsley","year":"2010","journal-title":"Acta Cryst."},{"key":"10.1016\/j.chembiol.2018.09.010_bib11","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1096\/fj.08-110494","article-title":"Doxycycline induces membrane expression of VE-cadherin on endothelial cells and prevents vascular hyperpermeability","volume":"22","author":"Fainaru","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.chembiol.2018.09.010_bib12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nprot.2016.011","article-title":"Transcriptome-wide interrogation of RNA secondary structure in living cells with icSHAPE","volume":"11","author":"Flynn","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.chembiol.2018.09.010_bib13","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1158\/1078-0432.CCR-13-1283","article-title":"Omacetaxine: a protein translation inhibitor for treatment of chronic myelogenous leukemia","volume":"20","author":"Gandhi","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.chembiol.2018.09.010_bib14","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nature13737","article-title":"Structural basis for the inhibition of the eukaryotic ribosome","volume":"513","author":"Garreau de Loubresse","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2018.09.010_bib15","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1378\/chest.124.5.2017","article-title":"Pulmonary capillary hemangiomatosis with atypical endotheliomatosis: successful antiangiogenic therapy with doxycycline","volume":"124","author":"Ginns","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.chembiol.2018.09.010_bib16","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1038\/ncomms2984","article-title":"Deregulation of translation due to post-transcriptional modification of rRNA explains why erm genes are inducible","volume":"4","author":"Gupta","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2018.09.010_bib17","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.cell.2013.04.036","article-title":"Structure of the mammalian ribosomal 43S preinitiation complex bound to the scanning factor DHX29","volume":"153","author":"Hashem","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2018.09.010_bib18","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1126\/science.8153629","article-title":"Structure of the Tet repressor-tetracycline complex and regulation of antibiotic resistance","volume":"264","author":"Hinrichs","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2018.09.010_bib19","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.14295","article-title":"Activation of GCN2 kinase by ribosome stalling links translation elongation with translation initiation","volume":"5","author":"Ishimura","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.chembiol.2018.09.010_bib20","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1021\/ja100014q","article-title":"Rapid Cu-free click chemistry with readily synthesized biarylazacyclooctynones","volume":"132","author":"Jewett","year":"2010","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2018.09.010_bib21","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.cell.2012.09.018","article-title":"Selective protein synthesis by ribosomes with a drug-obstructed exit tunnel","volume":"151","author":"Kannan","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2018.09.010_bib22","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/nature14427","article-title":"Structure of the human 80S ribosome","volume":"520","author":"Khatter","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2018.09.010_bib23","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5","article-title":"Click chemistry: diverse chemical function from a few good reactions","volume":"40","author":"Kolb","year":"2001","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.chembiol.2018.09.010_bib24","doi-asserted-by":"crossref","first-page":"7857","DOI":"10.1021\/ma020441y","article-title":"2-Oxepane-1,5-dione: a precursor of a novel class of versatile semicrystalline biodegradable (Co)polyesters","volume":"35","author":"Latere","year":"2002","journal-title":"Macromolecules"},{"key":"10.1016\/j.chembiol.2018.09.010_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/DBP.0b013e318287cd17","article-title":"A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile X syndrome","volume":"34","author":"Leigh","year":"2013","journal-title":"J.\u00a0Dev. Behav. Pediatr."},{"key":"10.1016\/j.chembiol.2018.09.010_bib26","doi-asserted-by":"crossref","first-page":"8551","DOI":"10.1002\/anie.201300683","article-title":"Design and synthesis of minimalist terminal alkyne-containing diazirine photo-crosslinkers and their incorporation into kinase inhibitors for cell- and tissue-based proteome profiling","volume":"52","author":"Li","year":"2013","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.chembiol.2018.09.010_bib27","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1161\/CIRCULATIONAHA.108.806505","article-title":"Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T\u00a0cells","volume":"119","author":"Lindeman","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.chembiol.2018.09.010_bib28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1073\/pnas.1111561108","article-title":"Imaging protein synthesis in cells and tissues with an alkyne analog of puromycin","volume":"109","author":"Liu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.chembiol.2018.09.010_bib29","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.phrs.2010.11.003","article-title":"Chemically modified non-antimicrobial tetracyclines are multifunctional drugs against advanced cancers","volume":"63","author":"Lokeshwar","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.chembiol.2018.09.010_bib30","doi-asserted-by":"crossref","first-page":"7971","DOI":"10.1128\/MCB.21.23.7971-7980.2001","article-title":"Translation initiation control by heme-regulated eukaryotic initiation factor 2alpha kinase in erythroid cells under cytoplasmic stresses","volume":"21","author":"Lu","year":"2001","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.chembiol.2018.09.010_bib31","doi-asserted-by":"crossref","first-page":"12622","DOI":"10.1038\/ncomms12622","article-title":"Ribosomal 18S rRNA base pairs with mRNA during eukaryotic translation initiation","volume":"7","author":"Martin","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2018.09.010_bib32","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.chembiol.2017.04.006","article-title":"Inhibition of eukaryotic translation by the antitumor natural product Agelastatin A","volume":"24","author":"McClary","year":"2017","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.chembiol.2018.09.010_bib33","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1056\/NEJMc053410","article-title":"Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs","volume":"354","author":"Moses","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chembiol.2018.09.010_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2015.02.034","article-title":"Tetracyclines disturb mitochondrial function across eukaryotic models: a call for caution in biomedical research","author":"Moullan","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.chembiol.2018.09.010_bib35","doi-asserted-by":"crossref","first-page":"12856","DOI":"10.1038\/ncomms12856","article-title":"Structure-function insights reveal the human ribosome as a cancer target for antibiotics","volume":"7","author":"Myasnikov","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2018.09.010_bib36","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/art.21620","article-title":"Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone","volume":"54","author":"O'Dell","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.chembiol.2018.09.010_bib37","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1073\/pnas.0900191106","article-title":"Identifying the proteins to which small-molecule probes and drugs bind in cells","volume":"106","author":"Ong","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2018.09.010_bib38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.molcel.2007.03.018","article-title":"The eukaryotic translation initiation factors eIF1 and eIF1A induce an open conformation of the 40S ribosome","volume":"26","author":"Passmore","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.chembiol.2018.09.010_bib39","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/emboj\/20.8.1829","article-title":"Crystal structures of complexes of the small ribosomal subunit with tetracycline, edeine and IF3","volume":"20","author":"Pioletti","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.chembiol.2018.09.010_bib40","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/emboj.2008.90","article-title":"Ribosomal position and contacts of mRNA in eukaryotic translation initiation complexes","volume":"27","author":"Pisarev","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.chembiol.2018.09.010_bib41","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.cell.2008.10.037","article-title":"Translation initiation on mammalian mRNAs with structured 5' UTRs requires DExH-box protein DHX29","volume":"135","author":"Pisareva","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2018.09.010_bib42","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/nprot.2007.261","article-title":"Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using Stage Tips","volume":"2","author":"Rappsilber","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.chembiol.2018.09.010_bib43","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrm2199","article-title":"Signal integration in the endoplasmic reticulum unfolded protein response","volume":"8","author":"Ron","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.chembiol.2018.09.010_bib44","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1200\/JCO.2001.19.2.584","article-title":"Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer","volume":"19","author":"Rudek","year":"2001","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.chembiol.2018.09.010_bib45","doi-asserted-by":"crossref","first-page":"e07314","DOI":"10.7554\/eLife.07314","article-title":"Pharmacological dimerization and activation of the exchange factor eIF2B antagonizes the integrated stress response","volume":"4","author":"Sidrauski","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.chembiol.2018.09.010_bib46","doi-asserted-by":"crossref","first-page":"9804","DOI":"10.1073\/pnas.1403586111","article-title":"Macrolide antibiotics allosterically predispose the ribosome for translation arrest","volume":"111","author":"Sothiselvam","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2018.09.010_bib47","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature14263","article-title":"Structural imprints in\u00a0vivo decode RNA regulatory mechanisms","volume":"519","author":"Spitale","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2018.09.010_bib48","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1158\/1078-0432.CCR-04-0804","article-title":"A phase I and pharmacokinetic study of Col-3 (Metastat), an oral tetracycline derivative with potent matrix metalloproteinase and antitumor properties","volume":"10","author":"Syed","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.chembiol.2018.09.010_bib49","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10557-005-5201-6","article-title":"Effect of matrix metalloproteinase inhibition by doxycycline on myocardial healing and remodeling after myocardial infarction","volume":"19","author":"Tessone","year":"2005","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.chembiol.2018.09.010_bib50","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nprot.2012.016","article-title":"Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks","volume":"7","author":"Trapnell","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.chembiol.2018.09.010_bib51","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1074\/mcp.O112.027094","article-title":"Refined preparation and use of anti-diglycine remnant (K-epsilon-GG) antibody enables routine quantification of 10,000s of ubiquitination sites in single proteomics experiments","volume":"12","author":"Udeshi","year":"2013","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.chembiol.2018.09.010_bib52","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1165\/rcmb.2013-0099OC","article-title":"Inhibition of epithelial to mesenchymal transition and pulmonary fibrosis by methacycline","volume":"50","author":"Xi","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.chembiol.2018.09.010_bib53","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.chembiol.2008.09.004","article-title":"Structural basis for specific, high-affinity tetracycline binding by an in\u00a0vitro evolved aptamer and artificial riboswitch","volume":"15","author":"Xiao","year":"2008","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2018.09.010_bib54","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S1474-4422(04)00937-8","article-title":"The promise of minocycline in neurology","volume":"3","author":"Yong","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.chembiol.2018.09.010_bib55","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.1128\/MCB.22.19.6681-6688.2002","article-title":"The GCN2 eIF2alpha kinase is required for adaptation to amino acid deprivation in mice","volume":"22","author":"Zhang","year":"2002","journal-title":"Mol. Cell Biol."}],"container-title":["Cell Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945618303301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945618303301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:32:16Z","timestamp":1762525936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451945618303301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S2451945618303301"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2018.09.010","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/256230","asserted-by":"object"}]},"ISSN":["2451-9456"],"issn-type":[{"value":"2451-9456","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tetracyclines Modify Translation by Targeting Key Human rRNA Substructures","name":"articletitle","label":"Article Title"},{"value":"Cell Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2018.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}